T H E   N I H    C A T A L Y S T     N O V E M B E R  –  D E C E M B E R  2002


In this issue, we are asking for your reactions in four areas: the NIH Research Festival, the new Clinical Research Information System, GME at NIH, and how NIH should go about breaking bad news.

Send your responses on these topics or your comments on other intramural research concerns to us via e-mail:
; fax:402-4303; or mail: Building 2, Room 2W23.


In Future Issues...

Elias Zerhouni: Settling In

The Greening of NHGRI

The 2nd Campus

1. What research made the strongest impression on you at this year’s Research Festival? Do you have any suggestions on how to improve attendance at next year’s Research Festival symposia and workshops?


2. What are your aspirations with regard to the new Clinical Research Information System, described in the commentary from the Clinical Center director (see page 2)?


3. Should NIH expand the number of ACGME-accredited programs (see pages 8—10)? In what areas?


4. How should NIH break the news–to the public and the scientific community– when a clinical trial must be or has been halted because the study regimen has been found wanting?
The NIH Catalyst is published bimonthly for and by the intramural scientists at NIH. Address correspondence to Building 2, Room 2W23, NIH, Bethesda, MD 20892. Ph: (301) 402-1449; fax: (301) 402-4303; e-mail: <catalyst@nih.gov>.

Michael Gottesman
Deputy Director for Intramural Research, OD

John I. Gallin
Director, Warren Grant Magnuson Clinical Center, and Associate Director for Clinical Research

Lance Liotta
Chief, Laboratory of Pathology, NCI


Celia Hooper

Fran Pollner

Shauna Roberts




Jorge Carrasquillo, CC
David Davies, NIDDK
Dale Graham, CIT
Hynda Kleinman, NIDCR
Elise Kohn, NCI
Susan Leitman, CC
Bernard Moss, NIAID
Michael Rogawski, NINDS
Joan Schwartz, NINDS
Gisela Storz, NICHD


Return to Table of Contents